Neurocrine publishes tardive dyskinesia scale validation research
Go back to Neurocrine publishes tardive dyskinesia scale validation research| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 156.04 +2.01 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.03 | 52 Week High | $58.46 | |||
| Open | $154.31 | 52 Week Low | $31.25 | |||
| Day High | $156.48 | P/E | N/A | |||
| Day Low | $153.70 | EPS | $-0.69 | |||
| Volume | 399,323 | |||||
